细菌素Sublancin对金黄色葡萄球菌的抑制作用及其机制的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
金黄色葡萄球菌是化脓感染中最常见的病原菌,所产肠毒素引起的食物中毒是世界性卫生难题。枯草芽孢杆菌产生的细菌素Sublancin,对金黄色葡萄球菌等革兰氏阳性菌有良好的抑菌活性。本研究以金黄色葡萄球菌甲氧西林敏感菌株CVCC1882和耐甲氧西林菌株ATCC43300为研究对象,研究了Sublancin对金黄色葡萄球菌CVCC1882和ATCC43300的体内体外抑菌效果及作用机制。(1) Sublancin对这两种菌均有良好的抑菌活性,最小抑菌浓度分别为3.75和60mg/L。(2)以耐甲氧西林金葡菌ATCC43300为研究对象,通过电镜等形态学方法研究Sublancin对菌体结构的影响,发现其主要是通过影响细菌菌体分裂进而抑制细菌生长。利用蛋白质组学的方法,通过Sublancin处理组与未处理组差异蛋白点的比较,得出Sublancin作用于细菌的靶位点主要涉及有关能量代谢、氨基酸代谢和氧化应激的蛋白。(3) Sublancin对金黄色葡萄球菌感染小鼠的体内抑菌效果。试验分成两部分,分别以CVCC1882和ATCC43300为试验菌株。其中,CVCC1882不产肠毒素且对甲氧西林敏感,而ATCC43300产肠毒素并且对甲氧西林耐药。两个试验设计相同:将160只体重为18-22g的SPF级昆明小鼠分成8组,每组20只。对照组腹腔注射0.5mL生理盐水,其他7组腹腔注射0.5mL1.0×1010CFU金黄色葡萄球菌。6h后,对照组腹腔注射05mL生理盐水,其他七组腹腔分别注射含有0、0.5、1.0、2.0和4.0mg/kg体重(body weight, BW)的Sublancin以及1.0和2.0mg/kg BW的氨苄西林。两个试验的结果都表明,Sublancin处理组显著降低了小鼠的死亡率,保护了小鼠肠道肠绒毛的完整性,促进了肠细胞增殖,降低了肠道炎症因子含量,抑制了NF-kB和iNOS的表达,减少了脾脏中凋亡细胞的数目,增加了脾脏中CD8细胞的数目。而本研究中,小鼠感染ATCC43300菌株后,由于金葡菌ATCC43300分泌的肠毒素具有超抗原特性,能强烈的刺激淋巴细胞(尤其是CD4细胞)的增殖,发现小鼠脾脏白髓比例升高,脾脏中CD4细胞数目显著升高,呈现增殖性炎症特征。Sublancin治疗后,小鼠脾脏白髓比例和CD4细胞数目降低。综上所述,Sublancin对金黄色葡萄球菌有良好的体外抑菌活性,其抑菌机制可能是通过抑制细菌的能量代谢而抑制了细菌的分裂。Sublancin对金黄色葡萄球菌同样有良好的体内活性,能有效的保护由于金葡菌感染所导致的肠道和脾脏的损伤。
Staphylococcus aureus is one of the most common pathogen in suppulative infection, and food poisoning caused by its enterotoxin is a globle health problem. Sublancin, a bacteriocin of the Bacillus subtilis, exerts powerful antibacterial activity against a broad spectrum of gram-positive bacteria including S. aureus. We have developed a highly efficient expression system using Bacillus subtilis800in order to obtain large amounts. To investigate the effect of sublancin on S. aureus and possible antibacterial mechanism, methicillin susceptible S. aureus CVCC1882and methicillin resistant S. aureus ATCC43300were used.(1) The minimal inhibitory concentrations of sublancin for the two stains are3.75and60mg/L, and exert powerful antibacterial activity.(2) In order to identify the intracellular target site. ATCC43300cells were incubated with sublancin and electron micrographs and proteomic analysis were done. Electron micrographs results confirmed that S. aureus cells division was interrupted. The differentially expressed S. aureus proteins involve in energy metabolism, amino acid metabolism and response to stress.(3) The effect of sublancin on S. aureus in vivo. The experiments were done using the two stains, respectively. A total of160, four week old mice were randomly assigned to1of8treatments. Mice in the control group were injected intraperitoneally with0.5mL of0.9%saline. Mice in the other seven groups were given an intraperitoneal injection of0.5mL saline containing1.0×1010CFU/mL S. aureus. Six hours after inoculation, mice in the control group were again injected with0.5mL of0.9%saline. Mice in the other seven groups were injected intraperitoneally with0.5mL of0.9%saline containing0,0.5,1.0,2.0or4.0mg/kg BW sublancin or1.0or2.0mg/kg BW ampicillin. The results showed that sublancin significantly reduced mice mortality. The height and the number of proliferated cells from the intestinal villi in the sublancin treated mice were higher than in the control. Sublancin also downregulated inflammatory cytokines, the NF-κB and iNOS in the intestine of mice. Sublancin also reduced the number of apoptosis cells and increased number of the CD8cells in spleen. ATCC43300express enterotoxins while CVCC1882doesn't, and enterotoxins sharply stimulate lymphocyte (especially CD4cells). Thus, the ratio of white pulp and the number of CD4cells in the spleen of mice increased significantly. After sublancin treatment, the ratio of white pulp and the number of CD4cells in the spleen of ATCC43300infected mice significantly decreased. In conclusion, sublancin powerfully inhibited S. aureus growth through inhibiting the energy metabolism and thus inhibiting the cell division. Sublancin also showed antibacterial effects in vivo and protect the intestine and spleen injury.
引文
陈杖榴主编.2002.兽医药理学.北京:中国农业出版社.pp 197.
    郭本恒主编.现代乳品加工.北京:中国轻工业出版社.pp 251-256.
    陆承平主编.2005.兽医微生物学.北京:中国农业出版社.pp 200-204.
    杨汉春主编.动物免疫学.北京:中国农业大学出版社.pp 15-80.
    张严峻,张俊彦,梅玲玲等.2005.金黄色葡萄球菌肠毒素基因的分型和分布.中国卫生检验杂志,15(6):682-684.
    Abo, T., T. Yamaguchi, F. Shimizu, et al.1976. Studies of surface immunoglobulins on human B lymphocytes. II. Characterization of a population of lymphocytes lacking surface immunoglobulins but carrying Fc receptor (SIg-Fc+ cell). J. Immunol.,117:1781-1787.
    Aly, S., J. Floury, M. Piot, et al.2012. The efficacy of nisin can drastically vary when produced in situ in model cheeses. Food Microbiol.,32:185-190.
    Archer, G. L.1998. Staphylococcus aureus:a well-armed pathogen. Clin Infect Dis.,26:1179-1181.
    Arnold, S. R.2007. Revenge of the killer microbe. CMAJ.,177:895-896.
    Barie, P. S.1998. Antibiotic-resistant gram-positive cocci:implications for surgical practice. World J. Surg.,22:118-126.
    Barkhatova, O. I., V. L. Popov, N. K. Kekcheeva, et al.1984. Electron microscopic characteristics of the action of penicillin and vancomycin on Rickettsia conorii and Rickettsia akari in vitro. Antibiotiki.,29:580-585.
    Bell, C. J., D. G. Gall, and J. L. Wallace.1995. Disruption of colonic electrolyte transport in experimental colitis. Am. J. Physiol.,268:G622-630.
    Biet, F., J. M. Berjeaud, R. W. Worobo, et al.1998. Heterologous expression of the bacteriocin mesentericin Y105 using the dedicated transport system and the general secretion pathway. Microbiology,144:2845-2854.
    Blount, P., S. I. Sukharev, P. C. Moe, et al.1999. Mechanosensitive channels of bacteria. Methods Enzymol.,294:458-482.
    Breukink, E., I. Wiedemann, C. van Kraaij, et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science,286:2361-2364.
    Brotz, H., M. Josten, I. Wiedemann, et al.1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol.,30:317-327.
    Brotz, H., G. Bierbaum, K. Leopold, et al.1998. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother.,42:154-160.
    Brown, D. F., D. I. Edwards, P. M. Hawkey, et al.2005. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J. Antimicrob. Chemother.,56:1000-1018.
    Campbell, N., X. Y. Yio, L. P. So, et al.1999. The intestinal epithelial cell:processing and presentation of antigen to the mucosal immune system. Immunol. Rev.,172:315-324.
    Campeau, J. L., S. Y. Salim, E. J. Albert, et al.2012. Intestinal epithelial cells modulate antigen-presenting cell responses to bacterial DNA. Infect Immun.,80:2632-2644.
    Chakicherla, A., and J. N. Hansen.1995. Role of the leader and structural regions of prelantibiotic peptides as assessed by expressing nisin-subtilin chimeras in Bacillus subtilis 168, and characterization of their physical, chemical, and antimicrobial properties. J. Biol. Chem., 270:23533-23539.
    Chambers, H. F., and M. A. Sande.1984. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or-resistant Staphylococcus aureus. Antimicrob. Agents Chemother.,26:61-64.
    Champney, W. S., and C. L. Tober.2000. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob. Agents Chemother., 44:1413-1417.
    Chan, C. W., E. Crafton, H. N. Fan, et al.2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med.,12:207-213.
    Chan, W. C., B. W. Bycroft, M. L. Leyland, et al.1993. A novel post-translational modification of the peptide antibiotic subtilin:isolation and characterization of a natural variant from Bacillus subtilis ATCC 6633. Biochem. J.,291 (Pt 1):23-27.
    Chaturvedi, L. S., and M. D. Basson.2013. Glucagonlike Peptide 2 analogue teduglutide:stimulation of proliferation but reduction of differentiation in human caco-2 intestinal epithelial cells. JAMA. Surg.,148:1037-1042.
    Chu, C., Y. Wei, S. T. Chuang, et al.2013. Differences in virulence genes and genome patterns of mastitis-associated Staphylococcus aureus among goat, cow, and human isolates in Taiwan. Foodborne pathogens and disease,10:256-262.
    Coffelt, S. B., and A. B. Scandurro.2008. Tumors sound the alarmin(s). Cancer. Res.,68:6482-6485.
    Cruz-Chamorro, L., M. A. Puertollano, E. Puertollano, et al.2006. In vitro biological activities of magainin alone or in combination with nisin. Peptides,27:1201-1209.
    Culos, K. A., J. P. Cannon, and S. A. Grim.2013. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Am. J. Ther.,20:200-212.
    Datta, R., H. Kojima, K. Yoshida, et al. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem.,272:20317-20320.
    Deitch, E. A.1993. Nutrition and the gut mucosal barrier. Curr. Opin. Gen. Surg.,9:85-91.
    Del-Val, M., and D. Lopez.2002. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes. Mol. Immunol.,39:235-247.
    Dobson, A., P. D. Cotter, R. P. Ross, et al.2012. Bacteriocin production:a probiotic trait? Appl. Environ. Microbiol.,78:1-6.
    Dohlsten, M., G. Hedlund, and T. Kalland.1991. Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol. Today,12:147-150.
    Dorenbos, R.2002. Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. J. Biol. Chem.,277:16682-16688.
    Draskovic, I., and D. Dubnau.2005. Biogenesis of a putative channel protein, ComEC, required for DNA uptake:membrane topology, oligomerization and formation of disulphide bonds. Mol. Microbiol.,55:881-896.
    Drider, D., G. Fimland, Y. Hechard, et al.2006. The continuing story of class Ila bacteriocins. Microbiol. Mol. Biol. Rev.,70:564-582.
    Drucker, D. J., P. Erlich, S. L. Asa, et al.1996. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. USA.,93:7911-7916.
    Dubnau, D.1999. DNA uptake in bacteria. Annu. Rev. Microbiol.,53:217-244.
    Dubois, J. Y., T. R. Kouwen, A. K. Schurich, et al.2009. Immunity to the bacteriocin sublancin 168 Is determined by the SunI (YolF) protein of Bacillus subtilis. Antimicrob. Agents. Chemother., 53:651-661.
    Erickson, H. P., D. W. Taylor, K. A. Taylor, et al.1996. Bacterial cell division protein FtsZ assembles into protofilament sheets and minirings, structural homologs of tubulin polymers. Proc. Natl. Acad. Sci. USA.,93:519-523.
    Fabianek, R. A., H. Hennecke, and L. Thony-Meyer.2000. Periplasmic protein thiol:disulfide oxidoreductases of Escherichia coli. FEMS. Microbiol. Rev.,24:303-316.
    Finlay, B. B., and G McFadden.2006. Anti-immunology:evasion of the host immune system by bacterial and viral pathogens. Cell,124:767-782.
    Fischer, H., M. Dohlsten, U. Andersson, et al.1990. Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells. J. Immunol.,144:4663-4669.
    Forder, R. E., G. S. Howarth, D. R. Tivey, et al,2007. Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry. Poult. Sci., 86:2396-2403.
    Frimodt-Moller, N.1993. The mouse peritonitis model:present and future use. J. Antimicrob. Chemother.,31 Suppl D:55-60.
    Fu, X. J., Y. Fang, and M. Yao.2013. Antimicrobial photodynamic therapy for methicillin-resistant Staphylococcus aureus infection. Biomed. Res. Int.,2013:159-157.
    Galvez, A., H. Abriouel, R. L. Lopez, et al.2007. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol.,120:51-70.
    Gamet, L., J. C. Murat, A. Remaury, et al.1992. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line. J. Cell Physiol.,150:501-509.
    Garcia De Gonzalo, C. V., L. Zhu, T. J. Oman, et al.2014. NMR structure of the s-linked glycopeptide sublancin 168. ACS. Chem. Biol.,9:796-801.
    Gennery, B. A., and G. L. Cooper.1988. Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections:vancomycin update. Br. J. Clin. Pract., Suppl 57:100-101.
    Gillet, Y., O. Dumitrescu, A. Tristan et al.2011. Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int. J. Antimicrob. Agents.,38:457-464.
    Gillor, O., and L. Ghazaryan.2007. Recent advances in bacteriocin application as antimicrobials. Recent Pat. Antiinfect. Drug Discov.,2:115-122.
    Gillor, O., J. A. Vriezen, and M. A. Riley.2008. The role of SOS boxes in enteric bacteriocin regulation. Microbiology,154:1783-1792.
    Goto, Y., B. Li, J. Claesen, et al.2010. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol.,8:el000339.
    Gradehandt, G., J. Hampl, N. Kleber, et al.1993. Requirements of exogenous protein antigens for presentation to CD4+ T lymphocytes by MHC class II-positive APC. Adv. Exp. Med. Biol., 329:23-27.
    Gregory, J. A., E. C. Becker, and K. Pogliano.2008. Bacillus subtilis MinC destabilizes FtsZ-rings at new cell poles and contributes to the timing of cell division. Genes& development, 22:3475-3488.
    Haidet, J., V. Cifarelli, M. Trucco, et al. 2012. C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia. Inflamm. Res.,61:27-35.
    Hale, J. D., N. C. Heng, R. W. Jack, et al.2005. Identification of nlmTE, the locus encoding the ABC transport system required for export of nonlantibiotic mutacins in Streptococcus mutans. J. Bacteriol.,187:5036-5039.
    Hasper, H. E., N. E. Kramer, J. L. Smith, et al.2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid Ⅱ. Science,313:1636-1637.
    Hayden, M. S., and S. Ghosh.2008. Shared principles in NF-kappaB signaling. Cell,132:344-362.
    Heng, N. C.2007. The diversity of bacteriocins in Gram-positive bacteria. In Bacteriocins. Springer Berlin Heidelberg, pp 45-92.
    Henriques, A. F., R. E. Jenkins, N. F. Burton, et al.2010. The intracellular effects of manuka honey on Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis.,29:45-50.
    Hetz, C., M. R. Bono, L. F. Barros, et al.2002. Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc. Natl. Acad. Sci. USA.,99:2696-2701.
    Hiramatsu, K., E. Suzuki, H. Takayama, et al.1990. Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother., 34:600-604.
    Hyde, A. J., J. Parisot, A. McNichol, et al.2006. Nisin-induced changes in Bacillus morphology suggest a paradigm of antibiotic action. Proc. Natl. Acad. Sci. USA.,103:19896-19901.
    Islam, M. R., J. Nagao, T. Zendo, et al.2012. Antimicrobial mechanism of lantibiotics. Biochem. Soc. Trans.,40:1528-1533.
    Ito, T., Y. Katayama, K. Asada, et al.2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother.,45:1323-1336.
    Johnson, C. D., and K. A. Kudsk.1999. Nutrition and intestinal mucosal immunity. Clin. Nutr., 18:337-344.
    Ju, S. T., H. Cui, D. J. Panka, et al.1994. Participation of target Fas protein in apoptosis pathway induced by CD4+ Thl and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA.,91:4185-4189.
    Juarranz, M. G., G. Bodega, J. C. Prieto, et al.2001. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation. Prostate,47:285-292.
    Kaneko, A., T. Mori, T. Fujino, et al.2000. An outbreak of enteritis induced by methicillin-resistant Staphylococcus aureus producing enterotoxin types A and C, toxic shock syndrome toxin-1 and coagulase type Ⅱ. Jpn. J. Infect Dis.,53:212-214.
    Karin, M.1999. The beginning of the end:IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem.,274:27339-27342.
    Katayama, Y., T. Ito, and K. Hiramatsu.2000. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents. Chemother.,44:1549-1555.
    Katis, V. L., R. G. Wake, and E. J. Harry.2000. Septal localization of the membrane-bound division proteins of Bacillus subtilis DivIB and DivIC is codependent only at high temperatures and requires FtsZ. J. Bacteriol.,182:3607-3611.
    Kaufmann, B. B., and D. T. Hung.2010. The fast track to multidrug resistance. Mol. Cell.,37:297-298.
    Klaenhammer, T. R.1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS. Microbiol. Rev.,12:39-85.
    Kleerebezem, M., R. Bongers, G Rutten, et al.2004. Autoregulation of subtilin biosynthesis in Bacillus subtilis:the role of the spa-box in subtilin-responsive promoters. Peptides,25:1415-1424.
    Klostermann, K.2010. Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis. J. Dairy. Res.,77:231-238.
    Kluytmans, J., W. van Leeuwen, W. Goessens, et al.1995. Food-initiated outbreak of methicillin-resistant Staphylococcus aureus analyzed by pheno-and genotyping. J. Clin. Microbiol.,33:1121-1128.
    Knudsen, J. D., K. Fuursted, S. Raber, et al.2000. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob. Agents. Chemother.,44:1247-1254.
    Kodani, S., M. E. Hudson, M. C. Durrant, et al.2004. The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor. Proc. Natl. Acad. Sci. USA.,101:11448-11453.
    Kouwen, T. R., E. N. Trip, E. L. Denham, et al.2009. The large mechanosensitive channel MscL determines bacterial susceptibility to the bacteriocin sublancin 168. Antimicrob. Agents. Chemother.,53:4702-4711.
    Kumagai, S., and K. Iwai.1990. Clinical significance of anti-PCNA autoantibody assay. Nihon. Rinsho., 48 Supp1:487-489.
    Kwiatek, M., S. Parasion, L. Mizak, et al.2012. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch. Virol.,157:225-234.
    Li, Y., J. Hsin, L. Zhao, et al.2013. FtsZ protofilaments use a hinge-opening mechanism for constrictive force generation. Science,341:392-395.
    Lin, R. Y., D. C. Saha, C. J. Bernstein, et al.1996. The pattern of inflammation in rat sepsis due to enterotoxin-producing Staphylococcus aureus:a comparison with ischemia-reperfusion injury. J. Med.,27:303-317.
    Liu, C. Y, W. S. Lee, C. P. Fung, et al.1996. Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Clin. Drug. Investig., 12:80-87.
    Ljunggren, H. G., R. Glas, J. K. Sandberg, et al.1996. Reactivity and specificity of CD8+T cells in mice with defects in the MHC class I antigen-presenting pathway. Immunol. Rev.,151:123-148.
    Loh, M. T., N. Srinivasan, S. H. Chan, et al.1995. Inhibition of staphylococcal enterotoxin-driven lymphocyte proliferation by anti-MHC class II monoclonal antibody. Hybridoma,14:429-433.
    Lowy, F. D.1998. Staphylococcus aureus infections. N. Engl. J. Med.,339:520-532.
    Lu, C., M. Reedy, and H. P. Erickson.2000. Straight and curved conformations of FtsZ are regulated by GTP hydrolysis. J. Bacteriol.,182:164-170.
    Luo, Y., and J. D. Helmann.2009. Extracytoplasmic function sigma factors with overlapping promoter specificity regulate sublancin production in Bacillus subtilis. J. Bacteriol.,191:4951-4958.
    Madara, J. L., and J. Stafford.1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest.,83:724-727.
    Madsen, K., A. Cornish, P. Soper, et al.2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology,121:580-591.
    Mainardi, J. L., D. M. Shlaes, R. V. Goering, et al.1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis.,171:1646-1650.
    Maqueda, M., A. Galvez, M. M. Bueno, et al.2004. Peptide AS-48:prototype of a new class of cyclic bacteriocins. Curr. Protein Pept. Sci.,5:399-416.
    McAuliffe, O., R. P. Ross, and C. Hill.2001. Lantibiotics:structure, biosynthesis and mode of action. FEMS. Microbiol. Rev.,25:285-308.
    McDaneld, P. M., L. M. Spooner, J. F. Mohr, et al.2013. Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 ug/mL. Ann. Pharmacother.,47:1654-1665.
    McDonald, R. R., N. A. Antonishyn, T. Hansen, et al.2005. Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol.,43:6147-6149.
    McPherson, S., R. Ellis, H. Fawzi, et al.2005. Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy:a case report and review of the literature. Eur. J. Gastroenterol. Hepatol.,17:1225-1227.
    Memmi, G., S. R. Filipe, M. G. Pinho, et al.2008. Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob. Agents Chemother.,52:3955-3966.
    Mendes, R. E.2012. Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia. J. Clin. Microbiol.,50:3694-3702.
    Mendez, R., A. Gutierrez, J. Reyes, et al.2012. The extracytoplasmic function sigma factor SigY is important for efficient maintenance of the Spbeta prophage that encodes sublancin in Bacillus subtilis. DNA Cell Biol.,31:946-955.
    Monroe, S., and R. Polk.2000. Antimicrobial use and bacterial resistance. Curr. Opin. Microbiol., 3:496-501.
    Morell, E. A., and D. M. Balkin.2010. Methicillin-resistant Staphylococcus aureus:a pervasive pathogen highlights the need for new antimicrobial development. Yale. J. Biol. Med., 83:223-233.
    Nakamura, Y., Y. Aramaki, and T. Kakiuchi.2001. A mouse model for postoperative fatal enteritis due to Staphylococcus infection. J. Surg. Res.,96:35-43.
    Nam, C., A. J. Case, B. S. Hostager, et al.2009. The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation. J. Mol. Neurosci.,37:160-167.
    Neurath, M. R, I. Fuss, B. L. Kelsall, et al.1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med.,182:1281-1290.
    Neurath, M. F., S. Pettersson, K. H. Meyer zum Buschenfelde, et al.1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med.,2:998-1004.
    Nikaido, H.1994. Maltose transport system of Escherichia coli:an ABC-type transporter. FEBS. Lett., 346:55-58.
    Noskin, G. A.2001. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management. Ann. Acad. Med. Singapore., 30:320-331.
    Oman, T. J., J. M. Boettcher, H. Wang, et al.2011. Sublancin is not a lantibiotic but an S-linked glycopeptide. Nat. Chem. Biol.,7:78-80.
    Origuchi, T., K. Eguchi, Y. Kawabe, et al.1995. Synovial cells are potent antigen-presenting cells for superantigen, staphylococcal enterotoxin B (SEB). Clin. Exp. Immunol.,99:345-351.
    Ossiprandi, M. C., and L. Zerbini.2014. Multiplex PCR and RPLA detection of enterotoxins in Staphylococcus aureus strains isolated from milk, dairy products and human faecal samples. J. Advances Biol.,4:312-317.
    Paalangara, R., S. McClure, and P. McCullagh.2003. Intestinal exposure to a parasite antigen in utero depresses cellular and cytokine responses of the mucosal immune system. Vet. Immunol. Immunopathol.,93:91-105.
    Paik, S. H., A. Chakicherla, and J. N. Hansen.1998. Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J. Biol. Chem.,273:23134-23142.
    Palavecino, E.2004. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin. Lab. Med.,24:403-418.
    Palavecino, E. L.2014. Clinical, epidemiologic, and laboratory aspects of methicillin-resistant Staphylococcus aureus infections. Methods. Mol. Biol.,1085:1-24.
    Perez-Bosque, A., and M. Moreto.2010. A rat model of mild intestinal inflammation induced by Staphylococcus aureus enterotoxin B. Proc. Nutr. Soc,69:447-453.
    Peterson, J. F., A. A. Dionisio, K. M. Riebe, et al.2010. Alternative use for spectra MRSA chromogenic agar in detection of methicillin-resistant Staphylococcus aureus from positive blood cultures. J. Clin. Microbiol.,48:2265-2267.
    Pieper, L., A. Godkin, U. Roesler, et al.2012. Herd characteristics and cow-level factors associated with Prototheca mastitis on dairy farms in Ontario, Canada. J. Dairy Sci.,95:5635-5644.
    Pilla, R., V. Castiglioni, M. E. Gelain, et al.2012. Long-term study of MRSA ST1, tl27 mastitis in a dairy cow. Vet. Rec.,170:312.
    Plunkett, F. J., M. V. Soares, M. Salmon, et al.2000. Regulation of apoptosis and replicative senescence in CD8+ T cell following acute viral infection. Apoptosis,5:431-434.
    Pontzer, C. H., M. J. Irwin, N. R. Gascoigne, et al.1992. T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc. Natl. Acad. Sci. USA., 89:7727-7731.
    Porter, A. G, and R. U. Janicke.1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ., 6:99-104.
    Prado Montes de Oca, E.2013. Antimicrobial peptide elicitors:new hope for the post-antibiotic era. Innate. Immun.,19:227-241.
    Pretolani, M., and M. Goldman.1997. IL-10:a potential therapy for allergic inflammation? Immunol. Today,18:277-280.
    Puppo, F., P. Contini, M. Ghio, and F. Indiveri.2002. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+cells by Fas/Fas-ligand interaction. Scientific World Journal,2: 421-423.
    Rogler, G, K. Brand, D. Vogl, et al.1998. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology,115:357-369.
    Rudd, C. E.1990. CD4, CD8 and the TCR-CD3 complex:a novel class of protein-tyrosine kinase receptor. Immunol. Today,11:400-406.
    Rust, C. J., F. Koning, and W. C. van Schooten.1993. Immobilized staphylococcal enterotoxin A is sufficient to induce T cell proliferation. Cell Immunol.,151:467-473.
    Rybak, M. J., and R. L. Akins.2001. Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance:clinical significance and treatment options. Drugs,61:1-7.
    Saadia, R., M. Schein, C. MacFarlane, et al.1990. Gut barrier function and the surgeon. Br. J. Surg., 77:487-492.
    Sargent, F., N. R. Stanley, B. C. Berks, et al.1999. Sec-independent protein translocation in Escherichia coli. J. Biol. Chem.,274:36073-36082.
    Savkovic, S. D., A. Koutsouris, and G. Hecht.1997. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am. J. Physiol.,273:C1160-1167.
    Scheffers, D. J., T. den Blaauwen, and A. J. Driessen.2000. Non-hydrolysable GTP-gamma-S stabilizes the FtsZ polymer in a GDP-bound state. Mol. Microbiol.,35:1211-1219.
    Schleifer, K. H., and O. Kandler.1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev.,36:407-477.
    Sieradzki, K., and A. Tomasz.1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol.,179:2557-2566.
    Siezen, R. J., O. P. Kuipers, and W. M. de Vos.1996. Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek,69:171-184.
    Sohn, M. H., J. W. Kim, W. K. Kim, et al.2003. Staphylococcal enterotoxin B upregulates fas-mediated apoptosis of peripheral blood mononuclear cells in childhood atopic dermatitis. Scand^J. Immunol.,57:62-67.
    Stevens, D. L.1997. Superantigens:their role in infectious diseases. Immunol. Invest.,26:275-281.
    Svetoch, E. A., B. V. Eruslanov, V. V. Perelygin, et al.2010. Inducer bacteria, unique signal peptides, and low-nutrient media stimulate in vitro bacteriocin production by Lactobacillus spp. and Enterococcus spp. strains. J. Agric. Food Chem.,58:6033-6038.
    Tsukita, S., and M. Furuse.1999. Occludin and claudins in tight-junction strands:leading or supporting players? Trends Cell Biol.,9:268-273.
    Tsutsuura, S., and M. Murata.2012. Temperature dependence of staphylococcal enterotoxin A production by Staphylococcus aureus. Nihon Rinsho,70:1323-1328.
    Ubukata, K., R. Nonoguchi, M. Matsuhashi, et al.1989. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J. Bacteriol.,171:2882-2885.
    van Belkum, M. J., D. J. Derksen, C. M. Franz, et al.2007. Structure function relationship of inducer peptide pheromones involved in bacteriocin production in Carnobacterium maltaromaticum and Enterococcus faecium. Microbiology,153:3660-3666.
    Vaudaux, P., P. Francois, B. Berger-Bachi, et al.2001. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J. Antimicrob. Chemother.,47:163-170.
    Vignali, D. A., C. Doyle, M. S. Kinch, et al.1993. Interactions of CD4 with MHC class II molecules, T cell receptors and p561ck. Philos Trans R. Soc. Lond. B. Biol. Sci.,342:13-24.
    Wadsworth, S., K. Yui, A. Yellen, et al.1989. Thy-1, CD4 and CD8 in T cell development. Year Immunol.,4:59-73.
    Wainwright, M.2000. Andre Gratia (1893-1950):forgotten pioneer of research into antimicrobial agents. J. Med. Biogr.,8:39-42.
    Wang, H., and W. A. van der Donk.2011. Substrate selectivity of the sublancin S-glycosyltransferase. J. Am. Chem. Soc.,133:16394-16397.
    Waseem, N. H., K. Labib, P. Nurse, et al.1992. Isolation and analysis of the fission yeast gene encoding polymerase delta accessory protein PCNA. EMBO. J.,11:5111-5120.
    Waseem, T., M. D. Frcs, S. W. Ashley, et al.2013. Ghrelin promotes intestinal epithelial cell proliferation through PI3K/Akt pathway and EGFR trans-activation both converging to ERK 1/2 phosphorylation. Peptides,52:113-134.
    Weedon, D.1990. Apoptosis. Adv. Dermatol.,5:243-255.
    Weir, D., C. Jones, L. Ammerman, et al.2007. Report of a strain of Staphylococcus caprae with the genes for enterotoxin A and enterotoxin-like toxin type P. J. Clin. Microbiol.,45:3476-3477.
    Wesson, C. A., L. E. Liou, K. M. Todd, et al.1998. Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect. Immun.,66:5238-5243.
    Willey, J. M., and W. A. van der Donk.2007. Lantibiotics:peptides of diverse structure and function. Annu. Rev. Microbiol.,61:477-501.
    Wood, K. L., H. L. Twigg,3rd, and A. I. Doseff.2009. Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci.,14:3771-3781.
    Woodford, N., M. Warner, and H. M. Aucken.2000. Vancomycin resistance among epidemic strains of methicillin-resistant Staphylococcus aureus in England and wales. J. Antimicrob. Chemother., 45:258-259.
    Wu, S. D., F. R. Zhang, Z. M. Huang, et al.2012. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli. Peptides, 35:225-230.
    Zhang, W., N. Fujii, and A. P. Naren.2012. Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas. Future Med. Chem., 4:329-345.
    Zidan, M., H. J. Schuberth, and R. Pabst.2000. Immunohistology of the splenic compartments of the one humped camel (Camelus dromedarius). Vet. Immunol. Immunopathol.,74:17-29.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700